SENOTHERAPEUTIX

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Dec 2024 filing date already counts against anyone who files later.

Record

Serial number

98919007

Mark type

Design + words

Filed

23 Dec 2024

Published for opposition

07 Apr 2026

Attorney of record

Jared L. DuJack

Goods and services

• Class 003 — Cosmetics and cleaning preparations: Anti-aging cream; Non-medicated anti-aging serum; Cosmetic anti-aging products, namely, anti-aging creams, serums, moisturizers, tonics, and cleansers; Cosmetic preparations; Cosmetic creams for skin care; Cosmetic preparations for skin care
• Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Synthesized peptides for use in treating age-related diseases and cancer; Synthesized peptides for use in skin conditions; Synthesized peptides, namely anti-aging peptides; Synthesized peptides for use in prevention of radiation damage; Synthesized peptides for use in treatment of radiation damage; Synthesized peptides for use in prevention of radiation related diseases; Synthesized peptides for use in treatment of radiation related diseases; Synthesized peptides for use in treatment of obesity; Synthesized peptides for use in weight loss regimens, Synthesized peptides for use in treatment of obesity in combination with other drugs; Synthesized peptides, namely, peptides for use in cosmetics; Synthesized peptides, namely, anti-aging peptides for use in cosmetics
• Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, and development of pharmaceutical preparations for age therapy and gene therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Cosmetic research; Development of cosmetic preparations; Research and development of cosmetic preparations; Gene therapy research; Gene therapy research related to anti-aging; Gene therapy research related to cancer; Gene therapy related to prevention and treatment of radiation damage and radiation related diseases; Gene therapy related to treatment of obesity; Gene therapy related to weight loss regimens; Gene therapy related to treatment of obesity in combination with other drugs; Anti-aging research; Medical research services; Medical research services, namely, anti-aging services; Medical research services, namely, prevention and treatment of age-related disorders
• Class 044 — Medical, beauty and agricultural services: Anti-aging therapy; Medical services, namely, anti-aging services; Medical testing services, namely, biologic age scoring; Medical testing services in the nature of statistical scoring to determine a biologic age score of a patient; Medical services; Medical services, namely, anti-aging services; Medical services, namely, prevention and treatment of age-related disorders; Medical advisory services; Medical advisory services, namely, anti-aging services; Medical advisory services, namely, prevention and treatment of age-related disorders; Medical testing services; Medical testing services, namely, anti-aging services; Medical testing services, namely, prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Medical testing services, namely, biopsy services; Medical testing services, namely, biopsy services related to biologic age; Medical testing services, namely, biopsy services related to biological age scoring; Medical testing services, namely, biopsy services related to determining a number or percentage of senescent cells; Laboratory services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Laboratory services related to biologic age, namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Laboratory services related to biological age scoring, namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, laboratory services related to determining a number or percentage of senescent cells; Non-invasive medical testing; Non-invasive medical testing related to biologic age; Non-invasive medical testing related to biological age scoring; Non-invasive medical testing related to determining a number or percentage of senescent cells; Medical care, namely, prevention of radiation damage; Medical care, namely, treatment of radiation damage; Medical care, namely, prevention of radiation related diseases; Medical care, namely treatment of radiation related diseases; Medical care, namely, treatment of obesity; Providing weight loss program services in the nature of weight loss regimens; Medical care, namely, treatment of obesity in combination with other drugs; Consulting services in the fields of medical care pertaining to anti-aging and cosmetics; Medical skin care services, namely, biologic age scoring for use in cosmetics; Medical care, namely, statistical scoring to determine a biologic age score of an individual

Owner

• SENOTHERAPEUTIX, Inc., Surfside, FL, US

Prosecution history

• 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 16 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 12 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 12 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 12 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 12 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 12 Dec 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 15 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 15 Sept 2025 — NON-FINAL ACTION E-MAILED
• 15 Sept 2025 — NON-FINAL ACTION WRITTEN
• 18 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 18 Jun 2025 — NON-FINAL ACTION E-MAILED
• 18 Jun 2025 — NON-FINAL ACTION WRITTEN
• 09 Jun 2025 — ASSIGNED TO EXAMINER
• 29 May 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED